Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases.
Cooper, James E
Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases. [electronic resource] - Clinical transplants 2010 - 415-20 p. digital
Publication Type: Case Reports; Journal Article
0890-9016
Adult
Boronic Acids--therapeutic use
Bortezomib
Chronic Disease
Female
Graft Rejection--immunology
Graft Survival--drug effects
HLA Antigens--immunology
Humans
Immunity, Humoral--drug effects
Immunosuppressive Agents--therapeutic use
Isoantibodies--blood
Kidney Transplantation--immunology
Male
Middle Aged
Protease Inhibitors--therapeutic use
Proteasome Endopeptidase Complex--metabolism
Proteasome Inhibitors
Pyrazines--therapeutic use
Time Factors
Treatment Outcome
Young Adult
Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases. [electronic resource] - Clinical transplants 2010 - 415-20 p. digital
Publication Type: Case Reports; Journal Article
0890-9016
Adult
Boronic Acids--therapeutic use
Bortezomib
Chronic Disease
Female
Graft Rejection--immunology
Graft Survival--drug effects
HLA Antigens--immunology
Humans
Immunity, Humoral--drug effects
Immunosuppressive Agents--therapeutic use
Isoantibodies--blood
Kidney Transplantation--immunology
Male
Middle Aged
Protease Inhibitors--therapeutic use
Proteasome Endopeptidase Complex--metabolism
Proteasome Inhibitors
Pyrazines--therapeutic use
Time Factors
Treatment Outcome
Young Adult